The safety and efficacy of chicken type II collagen on uveitis associated with juvenile rheumatoid arthritis

Ocular Immunology and Inflammation

Volumn 10, Issue 2, 2002, Pages 83-91

  Thompson, Darby J S ^a   Barron, Karyl S ^b   Whitcup, Scott M ^c,d,e   Robinson, Michael R ^c  

^a EMMES CORPORATION   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c NATIONAL EYE INSTITUTE   (United States)

^d ALLERGAN INC   (United States)

^e JULES STEIN EYE INSTITUTE   (United States)

Author keywords

Autoimmune; Collagen; Juvenile rheumatoid arthritis (JRA); Oral tolerance; Uveitis

Indexed keywords

COLLAGEN TYPE 2; COLLORAL;

ADOLESCENT; ADULT; ANTERIOR EYE CHAMBER; ARTICLE; BORDERLINE HYPERTENSION; CHICKEN; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE CALCULATION; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; HAZE; HUMAN; IMMUNE RESPONSE; JUVENILE RHEUMATOID ARTHRITIS; LOW DRUG DOSE; PAPULE; PROTEINURIA; PRURITUS; STOMACH PAIN; TREATMENT FAILURE; TREATMENT OUTCOME; UVEITIS; VISUAL ACUITY; VOMITING;

ADMINISTRATION, ORAL; ADOLESCENT; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; COLLAGEN TYPE II; FEMALE; HUMANS; MALE; PILOT PROJECTS; PROSPECTIVE STUDIES; SAFETY; UVEITIS, ANTERIOR;

EID: 0038670330     PISSN: 09273948     EISSN: None     Source Type: Journal    
DOI: 10.1076/ocii.10.2.83.13977     Document Type: Article

References (23)

1. Cassidy JT, Brody GL, Martel W. Monarticular juvenile rheumatoid arthritis. J Pediatr. 1967;70:867-875.
2. Bywaters EGL, Ansell BM. Monarticular arthritis in children. Ann Rheum Dis. 1965;24:116-122.
3. Schaller J, Kupfer C, Wedgwood RJ. Iridocyclitis in juvenile rheumatoid arthritis. Pediatrics. 1969;44:92-100.
4. Giannini EH, Cawkwell GD. Drug treatment in children with juvenile rheumatoid arthritis: past, present, and future. Pediatr Clin North Am. 1995;42:1099-1125.
5. Nussenblatt RB, Gery I, Weiner HL, Ferris FL, Shiloach J, Remaley N, Perry C, Caspi RR, Haller DA, Foster CS, Whitcup SM. Treatment of uveitis by oral administration of retinal antigens: results of a Phase I/II randomized masked trial. Am J Ophthalmol. 1997;123(5):583-592.
6. Thompson HSG, Staines NA. Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats. Clin Exp Immunol. 1986;64:581-586.
7. Nagler-Anderson C, Bober LA, Robinson ME, Siskind GW, Thorbeke FJ. Suppressions of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc Nat Acad Sci. 1986;83:7443-7446.
8. Zhang JZ, Lee CSY, Lider O, Weiner HL. Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen. J Immunol. 1990;145:2489-2493.
9. Thompson SJ, Thompson HSG, Harper N, et al. Prevention of pristane-induced arthritis by the oral administration of type II collagen. Immunology. 1993;79:152-157.
10. Trentham DE, Dynesius-Trentham RA, Orav EJ, Combitchi D, Lorenzo C, Sewell KL, Hafler DA, Weiner HL. Effects of oral administration of type II collagen on rheumatoid arthritis. Science. 1993;261:1727-1730.
11. Nussenblatt RB, Palestine AG, Chan CC, Roberge F. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology. 1985;92:467-471.
12. Nussenblatt RB, Whitcup SM, Palestine AG, Craven L (eds.) Examination of the patient with uveitis. In: Uveitis: Fundamentals and Clinical Practice. 2nd ed. St. Louis, MO: Mosby, 1996;58-68.
13. Ferris FL, Kassoff A, Bresnick GH, Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol. 1982;94:91-96.
14. Ferris FL, Sperduto RD. Standardized illumination for visual acuity testing in clinical research. Am J Ophthalmol. 1982;94:97-98.
15. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, Furst D, Goldmsith C, Kieszak S, Lightfoot R, Paulus H, Tugwell P, Weinblatt M, Widmark R, Williams HJ, Wolfe F. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum. 1993;36:729-740.
16. Singh G, Athreya B, Fries J, Goldsmith D. Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum. 1994;37:1761-1769.
17. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum. 1980;23:137-145.
18. Giannini E, Ruperto N, Ravelli A, Lovell D, Felson D, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum. 1997;40:1202-1209.
19. Sprent P (ed.) Categorical data. In: Applied Nonparametric Statistical Methods. 2nd ed. Glasgow: Chapman and Hall, 1993;209-247.
20. Casella G, Berger R, Kimmel J (eds.) Interval estimation. In: Statistical Inference. Belmont: Duxbury Press, 1990;403-460.
21. Barnett ML, Kremer Jm, Clair EW, et al. Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum. 1998;41:290-297.
22. Hauselmann HJ, Caravatti M, Seifert B, Wang K, Bruckner P, Stucki G, Michel BA. Can collagen type II sustain a methotrexate-induced therapeutic effect in patients with long-standing rheumatoid arthritis? A double-blind, randomized trial. Br J Rheumatol. 1998;37:1110-1117.
23. Barnett ML, Combitchi D, Trentham DE. A pilot trial of oral type II collagen in the treatment of juvenile rheumatoid arthritis. Arthritis Rheum. 1996;39:623-628.